Patent holdings for IPC class C07D 495/02

Total number of patents in this class: 107

10-year publication summary

7
5
5
5
5
4
3
7
1
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Rohm and Haas Electronic Materials Korea Ltd.
330
8
89bio Ltd
19
5
Korea Institute of Science and Technology
2118
4
Merck Patent GmbH
5873
3
Alantos Pharmaceuticals Holding, Inc.
13
3
Sunovion Pharmaceuticals Inc.
271
3
BASF SE
20892
2
Sumitomo Chemical Company, Limited
9031
2
Ecole Polytechnique Federale de Lausanne (epfl)
1536
2
Foghorn Therapeutics Inc.
123
2
Hanmi Holdings Co., Ltd
20
2
Neurocrine Biosciences, Inc.
409
2
PGI Drug Discovery LLC
30
2
The Scripps Research Institute
1347
2
Shanghai Jingxin Biomedical Co., Ltd.
15
2
Zhejiang Jingxin Pharmaceutical Co., Ltd.
21
2
Tolremo Therapeutics AG
21
2
Samsung Electronics Co., Ltd.
145025
1
Bristol-myers Squibb Company
4879
1
LG Chem, Ltd.
17594
1
Other owners 56